Scynexis (SCYX) Common Equity (2013 - 2026)
Scynexis (SCYX) reported Common Equity of $41.3 million for Q1 2026, down 18.26% on a YoY basis from $50.5 million in Q1 2025, and down 16.34% quarter-over-quarter from $49.4 million in Q4 2025.
Scynexis (SCYX) Common Equity (2013 - 2026) Analysis & Trends
Scynexis has reported Common Equity for 14 years, with the latest figure at $41.3 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 18.26% year-over-year to $41.3 million; the trailing twelve-month figure through Mar 2026 stood at $41.3 million (down 18.26% YoY), and the FY2025 full-year result was $49.4 million, down 10.35% from the prior year.
- Common Equity for Q1 2026 stood at $41.3 million, down from $49.4 million in the prior quarter.
- The five-year high for Common Equity was $93.1 million in Q2 2023, with the low at -$29.9 million in Q1 2023.
- Historically, Common Equity has averaged $47.2 million across 5 years, with a median of $49.4 million in 2025.
- The largest YoY upside for Common Equity was 2156.79% in 2023 against a maximum downside of 176.85% in 2023.
- Scynexis' Common Equity stood at $3.2 million in 2022, then surged by 2156.79% to $73.0 million in 2023, then dropped by 24.51% to $55.1 million in 2024, then slipped by 10.35% to $49.4 million in 2025, then dropped by 16.34% to $41.3 million in 2026.
- The last three Common Equity figures came in at $41.3 million (Q1 2026), $49.4 million (Q4 2025), and $36.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 41.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.31 Mn |
| Dec 31, 2025 | 49.38 Mn |
| Sep 30, 2025 | 36.43 Mn |
| Jun 30, 2025 | 44.47 Mn |
| Mar 31, 2025 | 50.53 Mn |
| Dec 31, 2024 | 55.08 Mn |
| Sep 30, 2024 | 58.53 Mn |
| Jun 30, 2024 | 60.41 Mn |
| Mar 31, 2024 | 74.11 Mn |
| Dec 31, 2023 | 72.96 Mn |
| Sep 30, 2023 | 91.99 Mn |
| Jun 30, 2023 | 93.08 Mn |
| Mar 31, 2023 | -29.91 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 17.21 Mn |
| Jun 30, 2022 | 45.48 Mn |
| Mar 31, 2022 | 38.93 Mn |
| Dec 31, 2021 | 41.26 Mn |
| Sep 30, 2021 | 37.61 Mn |
| Jun 30, 2021 | 32.32 Mn |